Vestal Point Capital’s Zimmer Biomet ZBH Stock Holding History

Vestal Point Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.2M	Buy	190,000 +40,000	+27%	+$3.67M	0.48%	54
2025 Q4	$13.5M	Buy	+150,000	New	+$14.2M	0.46%	45
2025 Q3	–	Sell	-50,000	Closed	-$4.56M	–	95
2025 Q2	$4.56M	Buy	+50,000	New	+$4.83M	0.24%	54

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestal Point Capital's ZBH Position: Q1 2026 in Review

Vestal Point Capital increased its Zimmer Biomet (ZBH) stake by 27% in Q1 2026, buying an estimated $3.67M and bringing the position to 190,000 shares worth $17.2M. The position accounts for 0.48% of the portfolio, ranked #54.

Vestal Point Capital first reported a position in ZBH in Q2 2025 and has held it in 3 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Vestal Point Capital held 190,000 shares of Zimmer Biomet worth $17.2M as of Q1 2026.
Vestal Point Capital bought 40,000 Zimmer Biomet shares in Q1 2026, an estimated $3.67M.
Zimmer Biomet made up 0.48% of Vestal Point Capital's portfolio in Q1 2026, its #54 holding.
Vestal Point Capital first reported a position in Zimmer Biomet in Q2 2025 and has held it in 3 quarters since.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.